New perspectives in the biology of depression;Nuevas perspectivas en la biología de la depresión

Revista Chilena de Neuro-Psiquiatria

Volumn 40, Issue SUPPL. 1, 2002, Pages 9-20

  Silva, Hernán ^a  

^a UNIVERSIDAD DE CHILE   (Chile)

Author keywords

Anxiety; Depression; Mood disorders; Stress

Indexed keywords

ANTIDEPRESSANT AGENT; CORTICOTROPIN RELEASING FACTOR; PROTIRELIN; THYROTROPIN;

ANXIETY; DEPRESSION; DISEASE PREDISPOSITION; ENDOCRINE FUNCTION TEST; GENETIC ANALYSIS; HYPOTHALAMUS HYPOPHYSIS ADRENAL SYSTEM; HYPOTHALAMUS HYPOPHYSIS THYROID SYSTEM; HYPOTHESIS; IMMUNOLOGICAL PROCEDURES; INJURY; LIFE EVENT; NEUROCHEMISTRY; NEUROENDOCRINE SYSTEM; RECURRENT DISEASE; REVIEW; STATISTICAL SIGNIFICANCE; STRESS;

EID: 31544473474     PISSN: 00347388     EISSN: 07179227     Source Type: Journal    
DOI: None     Document Type: Review

References (61)

1. Blazer DG, Kessler RC, McConagle KA, Swartz MS. The prevalence and distribution of major depression in a national community sample: the National Comorbidity Survey. Am J Psychiatry 1994; 151: 979-86
2. Vicente B, Rioseco P, Vielma M, Uribe M, Boggiano G, Torres S. Trastornos psiquiátricos en diez comunas de Santiago: prevalencia de seis meses. Revista de Psiquiatría 1992; 11(4):194-202
3. Murray CJ, López AD. Evidence-based health policy-lessons from the Global Burden of Disease Study. Science 1996; 274:740-3
4. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders. Fourth Edition (DSM-IV). Washington DC; American Psychiatric Press, 1994
5. Mayberg HS, Roderick MD, Mahurin K, Brannan SK. Neuropsychiatric Aspects of Mood and Affective Disorders. En: Yudofsky SC, Hales RE, eds. The American Psychiatric Textbook of Neuropsychiatry. Third Edition. Washington DC: American Psychiatric Press, 1997
6. Fava M, Kendler KS. Major depressive disorder. Neuron 2000; 28:335-41
7. Kessler RC. The effects of stressful life events on depression. Rev Psychol 1997; 48:191-214
8. Kaplan HI, Sadock BJ, Grebb JA: Mood disorders En Cancrow R, Gabbard GO, Jones RM, et al. eds. Synopsis of Psychiatry: Behavioral Sciences/Clinical Psychiatry. Baltimore: MD, Williams & Wilkins, 1994
9. Eysenck H. The biological basis of personality. Springfield: Charles C. Thomas, 1967
10. Waslick BD, Kandel R, Kakouros A. Depression in children and adolescents. An overview. En: Shafer D, Waslick BD, eds. The many faces of depression in children and adolescents. Washington DC: American Psychiatric Publishing Inc, 2002
11. Mueler TI, León AC. Recovery, chronicity and levels of psychopatology in major depression. Psychiat Clin North Am 1996; 19:85-102
12. Keller MB, Lavori PW, Klerman GL. Predictors of relapse in major depressive disorder. JAMA 1983; 250:3299-304
13. Post RM. Transduction of psychosocial stress into the neurobiology of recurrent affective disorder. Am J Psychiatry 1992; 149:999-1010
14. Sullivan PF, Neale MC, Kendler KS. The genetic epidemiology of major depression: Review and meta-analysis. Am J Psychiatry 2000; 157:1552-62
15. Von Knorring AL, Cloninger CR, Bohman M, Sigvardsson S. An adoption study of depressive disorders and substance abuse. Arch Gen Psychiatry 1983; 40:943-50
16. Cadoret RJ, O'Gorman TW, Heywood E, Troughton E. Genetic and environmental factors in major depression. J Affect Disord 1985; 9:155-64
17. Wender PH, Kety SS, Rosenthal D, Schulsinger F, Ortmann J, Lunde I. Psychiatric disorders in the biological and adoptive families of adopted individuals with affective disorders. Arch Gen Psychiatry 1986;43:923-9
18. Owen MJ, Cardno AG. Psychiatric genetics: progress, problems, and potential. Lancet 1999; 354(suppl I):11-4
19. Tsuang MT, Faraone SW. The genetics of mood disorders. Baltimore MD: The John Hopkins University Press, 1990
20. Kendler KS, Gardner CO, Prescott CA. Clinical characteristics of major depression that predict risk of depression in relatives. Arch Gen Psychiatry 1999; 56:322-7
21. Kendler KS, Kessler RC, Walters EE, McLean CJ, Sham PC, Neale MC, Heath AC, Eaves LJ. Stressful life events, genetic liability and onset of an episode of major depression in women. Am J Psychiatry 1995; 152:833-42
22. Schildkraut JJ. The catecholamine hypothesis of affective disorders: a review of supporting evidence. Am J Psychiatry 1965; 122:509-22
23. Siever LJ, Buchsbaum MS, New AS, Spiegel-Cohen J, Wei T, Hazlett EA et al. D,L-Fenfluramine response in impulsive personality disorder assessed with [18F]fluorodesoxyglucose positron emission tomography. Neuropsychopharmacology 1999; 20:413-23
24. Owens MJ, Nemeroff CB. Role of serotonin on the pathophysiology of depression: focus on the serotonin transporter. Clin Chem 1994; 40:288-95
25. Stockmeier CA, Shapiro LA, Dilley GE, Kolli TN, Friedman L, Rajkowska G. Increase in serotonin 1A autoreceptors in the midbrain of suicide victims with major depression - postmortem evidence for decreased serotonin activity. J Neurosci 1998; 18:7394-401
26. Sargent PA, Kjaer KH, Bench CJ, Rabiner EA, Messa C, Meyer J et al. Brain serotonin 1A receptor binding measured by positron emission tomography with [11C]WAY-100635: effects of depression and antidepressant treatment. Arch Gen Psychiatry 2000; 57:174-80
27. Malison RJ, Price LH, Berman R, Van Dycck CH, Pelton GH, Carpenter L et al. Reduced brain serotonin transporter availability in major depression as measured by [123I]-2 beta-carbomethoxy-3beta-4-iodophenyl-tropane and single photon emission computed tomography. Biol Psychiatry 1998; 44:1090-8
28. Klimek V, Stockmeier C, Overholzer J, Meltzer HY, Kalka S, Dilley G et al. Reduced levels of norepinephrine transporters in the locus coeruleus in major depression. J Neurosci 1997; 17:8451-8
29. Tizabi Y, Rezvanil AH, Russell LT, Tyler KY, Overstreet DH. Depressive characteristics of FSL rats: involvement of central nicotine receptors. Pharmacol Biochem Behav 2000; 66:73-7
30. Cantello R, Aguaggia M, Gilli M. Major depression in Parkinson's disease and the mood response to intravenous methylphenidate: possible role of the "hedonic" dopamine synapse. J Neurol Neurosurg Psychiatry 1989; 52:724-31
31. Nemeroff CB, Ranga K, Krishnan R. Neuroendocrine alterations in psychiatric disorders. En Nemeroff CB ed. Neuroendocrinology. Boca Raton FL, CRC Press, 1992
32. Arana GW, Baldessarini RJ, Brown WA. The dexamethasone suppression test: an overview of its current status in psychiatry. Task Force Report for the American Psychiatric Association. Washington DC, American Psychiatric Association, 1987
33. Raadsher FC, Hoogendijk WJ, Stam FC. Increased numbers of CRH expressing neurons in the hypothalamic paraventricular nucleus of depressed patients. Neuroendocrinology 1994; 60:436-44
34. Raadsher FC, Van Heerikhuize JJ, Lucassen PJ. Corticotrophin-releasing hormone mRNA levels in the paraventricular nucleus of patients with Alzheimer disease and depression. Am J Psychiatry 1995;152:1372-6
35. Axelson DA, Doraiswamy PM, Boyko O. In vivo assessment of pituitary volume with magnetic resonance imaging and systematic steorology: relationship to dexamethasone suppression test results in patients. Psychiatry Res 1992;44:63-70
36. O'Toole JM, Sekula LK, Rubin TJ. Pituitary-adrenal cortical axis measures as predictors of sustained remission in major depression. Biol Psychiatry 1997; 42:85-9
37. Rubin RT, Phillips JS, McCracken JT. Adrenal gland volume in major depression: relationship to basal and stimulated pituitary-adrenal cortical axis function. Biol Psychiatry 1996;40:89-97
38. Beck-Friss J, Ljuggren JG, Thoren M. Melatonin, cortisol, and ACTH in patients with major depressive disorder and healthy human with special reference to the outcome of the dexamethasone suppression test. Psychoneuroendocrinology 1985;10:173-86
39. Holsboer F, Barden N. Antidepressants and hypothalamic-pituitary- adrenocortical regulation. Endocr Rev 1996;17:187-205
40. Sapolsky RM. Stress, glucocorticoids, and damage to the nervous system: the current state of confusion. Stress 1996;1:1-19
41. Weeke A, Weeke J. Disturbed circadian variation of serum thyrotrophin in patients with endogenous depression. Acta Psychiatr Scand 1978; 57: 281-9
42. Banki CM, Bissette G, Arato M. Elevation of inmunoreactive CSF-TRH in depressed patients. Am J Psychiatry 1988; 145:1526-31
43. Hansen-Grant SM, Pariante CM, Kalin NH. Neuroendocrine and inmune system pathology in psychiatric disease. En Schatzberg AF, Nemeroff CB eds. Textbook of Psychopharmachology. Washington DC: American Psychiatric Press, 1998
44. Marangell LB, George MS, Callahan AM. Effects of intrathecal thyrotrophin-releasing hormone (protirelin) in refractory depressed patients. Arch Gen Psychiatry 1997; 54:214-22
45. Nemeroff CB, Simon JS, Haggerty JJ. Antithyroid antibodies in depressed patients. Am J Psychiatry 1985;142:840-3
46. Mendlewicz J, Linkowski P, Kerkhofs M. Diurnal hypersecretion of growth hormone in depression. J Clin Endocrinol Metab 1985; 60:505-12
47. Charney DS, Henninger GR, Steinberg DE. Adrenergic receptor sensitivity in depression: effects of clonidine in depressed patients and healthy subjects. Arch Gen Psychiatry 1982; 39: 290-4
48. Stein M, Miller AH, Trestman RL. Depression, the immune system, and health and illness. Arch Gen Psychiatry 1991; 48:171-7
49. Miller AH. Neuroendocrine and immune system interactions in stress and depression. Psychiat Clin North Am 1998; 21:443-63
50. Schleifer SJ, Keller SE, Bond RN. Major depressive disorder and immunity: role of age, sex, severity and hospitalization. Arch Gen Psychiatry 1989; 46:81-7
51. Maes MA. A review on the acute phase response in major depression. Rev Neurosci 1993; 4:407-16
52. Besedovsky HO, Del Rey A. Inmune-neuroendocrine interaction: facts and hypotheses. Endocr Rev 1996; 17:64-102
53. Yirmiya R. Endotoxin produces a depressive-like episodes in rats. Brain Res 1996; 711:163
54. Hill MR, Stith RD, McCallum RE. Interleukin 1: a regulatory role in glucocorticoid-regulated hepatic metabolism. J Inmunol 1986; 137:858-62
55. Dunn AJ, Wang J. Cytokine effects on CNS biogenic amines. Neuroinmunomodulation 1995; 2:319
56. Mayberg HS. Limbic-cortical dysregulation: a proposed model of depression. J Neropsychiatry Clin Neurosci 1997; 9:471-81
57. Soares JC, Mann JJ. The anatomy of mood disorders - review of structural neuroimaging studies. Biol Psychiatry 1997; 47:86-106
58. Devets WC. Neuroimaging studies of major depression. En: Morihisa JM, ed. Advances in brain imaging. Washington DC: American Psychiatric Publishing Inc, 2001
59. Buchsbaum MS, Wu J, Spiegel BV, Hackett E, Tienary M, Abel J et al. Effect of sertraline on regional metabolic rate in patients with affective disorder. Biol Psychiatry 1997; 41:15-22
60. Heim C, Nemeroff CB. The role of childhood trauma in the neurobiology of mood and anxiety disorders: preclinical and clinical studies. Biol Psychiatry 2001; 49:1023-39
61. Musselman DL, Evans DL, Nemeroff CB. The relationship of depression to cardiovascular disease. Epidemiology, biology and treatment. Arch Gen Psychiatry 1998; 55:580-92